Search for: "Amgen Inc. v. Sanofi"
Results 81 - 100
of 105
Sorted by Relevance
|
Sort by Date
14 Jun 2024, 11:25 am
” Citing Amgen Inc. v. [read post]
18 Mar 2010, 2:30 am
Amgen, Inc. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
26 Sep 2022, 4:49 am
Sanofi, No. 21-757 Amgen also fits well as a companion case to Juno v. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
24 Feb 2022, 6:12 pm
” Full Scope Enablement: Amgen v. [read post]
19 May 2023, 4:03 pm
The justices ruled in favor of social media companies in Twitter, Inc. v. [read post]
9 Jun 2023, 8:20 am
Goldsmith for copyrights and Amgen Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
29 Nov 2023, 8:41 am
The Federal Circuit rejected this argument based on dicta in Thryv, Inc. v. [read post]
2 Dec 2011, 2:00 pm
Amgen, Inc., ___ F. [read post]
3 Oct 2018, 8:51 am
Amgen Inc. v. [read post]
22 Feb 2008, 1:30 pm
The decision in Reidel v. [read post]
22 Jul 2024, 12:07 am
In the following I will focus on Decision CC_586764/2023 (UPC_14/2023), which is the counterclaim for revocation in the infringement action between Amgen Inc and Regeneron Pharmaceuticals Inc. that Amgen filed on the very first day when the UPC opened its doors (1 June 2023), a few minutes after Sanofi (Regeneron’s licensee) had filed a revocation action at the Central Division, which became the UPC’s very first case ever (UPC_1/2023). [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
